Table Of Contents
1. Market Context & Strategic Relevance
1.1 Opening Context (Why the market matters)
1.1.1 Why This Market Is Gaining Strategic Attention
1.1.2 Business Decisions This Report Supports
1.2 Scope
1.3 Research & Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size By Test Type
2.3.2 Market Size By Product
2.3.3 Market Size By Method
2.3.4 Market Size By End Use
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material & Diagnostic Component Suppliers
3.4.2 Blood Testing Equipment & Reagent Manufacturers
3.4.3 Diagnostic Laboratories & Service Providers
3.4.4 Healthcare Providers & End Users
3.5 Industry Life Cycle Assessment
4. Statistical Insights & Trends Reporting
4.1 Diagnostic Technology & Automation Metrics
4.1.1 Share (%) of blood testing technologies utilizing automated analyzers, point-of-care testing, molecular diagnostics, immunoassays, and advanced laboratory platforms.
4.1.2 Growth (%) in adoption of automated and high-throughput blood testing technologies during 2025 and 2026.
4.1.3 Increase (%) in AI-assisted diagnostics, digital laboratory systems, and automated sample processing capabilities.
4.2 Test Accuracy & Performance Metrics
4.2.1 Share (%) of blood testing platforms achieving improvements in sensitivity, specificity, turnaround time, and analytical accuracy.
4.2.2 Growth (%) in adoption of high-sensitivity assays, multiplex testing, and rapid diagnostic technologies.
4.2.3 Increase (%) in development of minimally invasive, low-volume, and rapid blood testing methods.
4.3 Point-of-Care & Personalized Diagnostics Metrics
4.3.1 Share (%) of blood tests performed through point-of-care, decentralized, and portable diagnostic platforms.
4.3.2 Growth (%) in adoption of home-based and near-patient blood testing technologies.
4.3.3 Increase (%) in personalized diagnostics, biomarker-based testing, and data-driven interpretation of blood test results.
4.4 Digitalization & Innovation Metrics
4.4.1 Share (%) of blood testing systems incorporating AI, machine learning, cloud connectivity, and laboratory information management technologies.
4.4.2 Growth (%) in investments in next-generation blood diagnostics, multiplex platforms, biosensors, and advanced analytical technologies.
4.4.3 Increase (%) in integration of blood testing platforms with electronic health records, remote monitoring, and digital diagnostic ecosystems.
5. Blood Testing Market Segmental Analysis & Forecast, By Test Type, 2022–2035, Value (USD Billion)
5.1 Introduction
5.2 Glucose Testing
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022–2035
5.3 Complete Blood Count
5.4 Lipid Profile Testing
5.5 Infectious Disease Testing
5.6 Coagulation Testing
5.7 A1C Testing
5.8 Kidney/Renal Function Testing
5.9 Liver Function Testing
5.10 Cancer/Oncology Testing
5.11 Others
6. Blood Testing Market Segmental Analysis & Forecast, By Product, 2022–2035, Value (USD Billion)
6.1 Introduction
6.2 Reagents and Kits
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022–2035
6.3 Instruments
6.4 Software and Services
7. Blood Testing Market Segmental Analysis & Forecast, By Method, 2022–2035, Value (USD Billion)
7.1 Introduction
7.2 Automated
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022–2035
7.3 Manual
8. Blood Testing Market Segmental Analysis & Forecast, By End Use, 2022–2035, Value (USD Billion)
8.1 Introduction
8.2 Hospitals and Clinics
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022–2035
8.3 Diagnostic Laboratories
8.4 Home Care Settings
8.5 Blood Banks
8.6 Research Institutions/Laboratories
8.7 Others
9. Blood Testing Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Blood Testing Market Size & Forecast, By Test Type, 2022–2035
9.2.3 Blood Testing Market Size & Forecast, By Product, 2022–2035
9.2.4 Blood Testing Market Size & Forecast, By Method, 2022–2035
9.2.5 Blood Testing Market Size & Forecast, By End Use, 2022–2035
9.2.6 Blood Testing Market Size & Forecast, By Country, 2022–2035
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 Blood Testing Market Size & Forecast, By Test Type, 2022–2035
9.3.3 Blood Testing Market Size & Forecast, By Product, 2022–2035
9.3.4 Blood Testing Market Size & Forecast, By Method, 2022–2035
9.3.5 Blood Testing Market Size & Forecast, By End Use, 2022–2035
9.3.6 Blood Testing Market Size & Forecast, By Country, 2022–2035
9.3.6.1 Germany
9.3.6.2 UK
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Blood Testing Market Size & Forecast, By Test Type, 2022–2035
9.4.3 Blood Testing Market Size & Forecast, By Product, 2022–2035
9.4.4 Blood Testing Market Size & Forecast, By Method, 2022–2035
9.4.5 Blood Testing Market Size & Forecast, By End Use, 2022–2035
9.4.6 Blood Testing Market Size & Forecast, By Country, 2022–2035
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 Blood Testing Market Size & Forecast, By Test Type, 2022–2035
9.5.3 Blood Testing Market Size & Forecast, By Product, 2022–2035
9.5.4 Blood Testing Market Size & Forecast, By Method, 2022–2035
9.5.5 Blood Testing Market Size & Forecast, By End Use, 2022–2035
9.5.6 Blood Testing Market Size & Forecast, By Country, 2022–2035
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Blood Testing Market Size & Forecast, By Test Type, 2022–2035
9.6.3 Blood Testing Market Size & Forecast, By Product, 2022–2035
9.6.4 Blood Testing Market Size & Forecast, By Method, 2022–2035
9.6.5 Blood Testing Market Size & Forecast, By End Use, 2022–2035
9.6.6 Blood Testing Market Size & Forecast, By Country, 2022–2035
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 South Africa
9.6.6.5 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Year-Wise Strategies & Development, 2022–2026
10.3 Market Share Analysis, 2025
10.4 Test Type/Service & Product Benchmarking
10.4.1 Test Type/Service Specifications & Features By Key Players
10.4.2 Test Type/Service Heatmap By Key Players
10.4.3 Product Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Abbott Laboratories
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Test Type/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 Geographical Presence
10.6.1.5 SWOT Analysis
10.6.2 F. Hoffmann-La Roche Ltd.
10.6.3 Siemens Healthineers AG
10.6.4 Danaher Corporation (Beckman Coulter)
10.6.5 Becton, Dickinson and Company
10.6.6 Thermo Fisher Scientific Inc.
10.6.7 bioMerieux SA
10.6.8 Sysmex Corporation
10.6.9 QuidelOrtho Corporation
10.6.10 Quest Diagnostics Incorporated
10.6.11 Laboratory Corporation of America Holdings
10.6.12 Bio-Rad Laboratories, Inc.
10.6.13 Revvity, Inc.
10.6.14 Grifols S.A.
10.6.15 Agilent Technologies, Inc.
10.6.16 Sekisui Diagnostics
10.6.17 Randox Laboratories Ltd.
10.6.18 EKF Diagnostics Holdings plc
10.6.19 Trinity Biotech plc
10.6.20 Mindray Medical International Limited
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions on Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
Frequently Asked Questions
Key players include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Danaher Corporation, and Becton, Dickinson and Company, among other diagnostics manufacturers.
Continued development of novel blood-based biomarker tests and continued expansion of point-of-care blood testing represent the primary opportunities.
Growth is primarily driven by the growing burden of chronic and infectious diseases, combined with continued laboratory automation.
By Test Type, Glucose Testing dominated the market in 2025, reflecting the enormous and still-growing global diabetic patient population.
North America dominated the market with a 34.65% share in 2025, supported by a vast clinical laboratory infrastructure and broad insurance coverage.